Position in ELAN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$375,581
+$20,404 QoQ
Shares Held
15,695
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $45,054,973 across 12 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
270,642 | $31,992,590 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
148,384 | $4,469,326 | |
| 3 | VTRS |
Viatris Inc
|
257,647 | $3,480,810 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,465 | $1,461,695 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
250,795 | $1,354,293 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,544 | $730,366 | |
| 7 | HLN |
Haleon plc
|
53,465 | $535,184 | |
| 8 | ELAN |
Elanco Animal Health Inc
This page
|
15,695 | $375,581 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $375,581 | 15,695 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $355,177 | 15,695 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $316,097 | 15,695 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $245,273 | 17,176 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $180,348 | 17,176 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $203,508 | 16,805 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $235,157 | 16,008 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $223,592 | 15,495 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $252,258 | 15,495 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $230,875 | 15,495 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $174,163 | 15,495 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $155,879 | 15,495 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $176,710 | 18,799 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $215,939 | 17,671 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $289,153 | 23,300 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $456,161 | 23,238 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $614,106 | 23,538 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $664,489 | 23,414 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $663,184 | 20,796 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $615,192 | 17,734 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $521,353 | 17,703 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $435,452 | 14,198 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $400,320 | 14,333 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $301,629 | 14,062 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $318,878 | 14,242 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||